PHARMED UG · KNOWLEDGE BASE

Scientific Sources and Regulatory References

Primary sources from German and European regulators, clinical research databases and public health agencies, clearly distinct from our development prototypes.

Research about a substance, plant or strain does not demonstrate the efficacy or commercial authorization of a Pharmed UG finished product. An EMA herbal monograph cannot be transferred automatically to a food supplement.

How to interpret these sources

Regulatory law determines market requirements. Safety opinions inform risk assessments. Scientific studies inform possible mechanisms and effects under defined conditions. Marketing permission requires product-level compliant claims and labeling.

Browse 13 transparent formulations →

New concepts: nasal spray and D3 + K2 blister tablets

15 mL saline nasal spray: A nasal spray is not a food supplement. Its proposed intended use and principal mechanism determine whether medical-device or medicinal-product rules apply. Packaging, microbiological control and any claims require expert evaluation. BfArM classification guidance ↗.

30 blister-packed D3 + K2 tablets: A non-final supplement concept is being evaluated using a provisional adult daily target of vitamin D3 20 µg and K2 25 µg. The image displays different amounts (25 µg D3 + 75 µg K2); these are not verified label values. BfR discusses proposed recommended maximum contents and warns about vitamin K with anticoagulants. BfR source ↗.

Neither concept is an approved product. The generated images should be used only with clear development/mockup disclaimers.